Akoğlu Ertap, Görür Sadik, Atik Esin, Okuyucu Semsettin, Sangün Ozlem
Mustafa Kemal University, Faculty of Medicine, Department of Oto-Rhino-Laryngology, Head and Neck Surgery, 31100 Antakya, Hatay, Turkey.
Int J Pediatr Otorhinolaryngol. 2006 Nov;70(11):1919-22. doi: 10.1016/j.ijporl.2006.06.019. Epub 2006 Aug 9.
To determine any possible adverse effect of 1-deamino 8-D-arginine vasopressin (DDAVP) spray on nasal cytology and mucociliary clearance in patients with nocturnal enuresis.
Twenty-two children aged 6-16 enrolled in the study. Epithelial surface cells samples were taken from the nasal mucosa and mucociliary clearance time was calculated before and 1 and 6 months after administration of DDAVP spray.
No qualitative changes in the epithelial surface cells and mucociliary clearance time were observed at 1 and 6 months after therapy.
Based on the findings of the present study, DDAVP spray can be used for 6 months in children without apparent risk of damage to the epithelial surface cells and mucociliary clearance time.